Skip to content

The status quo and influencing factors of elderly patients with chronic disease involvement in medication safety behavior during hospital-family transitional period

The status quo and influencing factors of elderly patients with chronic disease involvement in medication safety behavior during hospital-family transitional period

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072083
Enrollment
Unknown
Registered
2023-06-02
Start date
2023-06-02
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic diseases of the elderly

Interventions

case series:None

Sponsors

Fujian Medical University School of Nursing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Has been diagnosed with at least one chronic disease by a second level or higher hospital; 2. Age = 60 years old; 3. After discharge, use at least one medication for treatment; 4. After discharge and returning to home; 5. The discharge time is less than 2 months; 6. Participate in this study with informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who need to be transferred to other medical institutions for further treatment due to their illness after discharge; 2. Critical and/or end-stage patients with easily changing conditions; 3. Those who cannot take care of themselves; 4. Individuals with hearing, visual impairment, or communication difficulties with others.

Design outcomes

Primary

MeasureTime frame
patient involvement in medication safety;

Secondary

MeasureTime frame
Health literacy;Healthcare worker support;Family support;self-efficacy;

Countries

China

Contacts

Public ContactLin Ting

Fujian Medical University School of Nursing

fjswbhjx@sina.com+86 136 0953 2214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026